MedPath

Effect of ultrafiltration on kidney functio

Phase 2
Conditions
Condition 1: Chronic Ischemic Heart Disease. Condition 2: Acute Renal Failure with tubular necrosis.
Chronic ischaemic heart disease
Acute renal failure
Registration Number
IRCT201103053438N3
Lead Sponsor
rology and Nephrology Research Center
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
200
Inclusion Criteria

Patients with coronary artery disease or vavular disease that come for elective first time on-pump operation will be recruited for the study.
Exclusion criteria:cre>1.5mg/dl, less than 3 days interval between angiography( dye contrast) till operation, urinary infection( presence of bacteria on urinary exam),Chronic lung disease(history of bronchodilator use or FEV1 less than 60%on spirometry), combine operation(coronary and valve) and urgent/emergency cases

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
rinary NGAL. Timepoint: 2 TIMES2 TIMES(after urinary caheterizaion, and 2 hours after arrival at the intensive care unit). Method of measurement: ELISA.
Secondary Outcome Measures
NameTimeMethod
Serum creatinin. Timepoint: daily for 4 days. Method of measurement: laboratory equipment.;Intubation time. Timepoint: from entry to ICU till extubation. Method of measurement: hour.;Blood product requirement. Timepoint: during operation. Method of measurement: unit.;Chest tube drainage. Timepoint: from entry to ICU till chest tube removal. Method of measurement: ml.
© Copyright 2025. All Rights Reserved by MedPath